Visceral fat accumulation is known to be a clinical index for insulin resistance related to obesity [1±3]. Patients with excessive accumulation of visceral fat frequently suffered from metabolic disorders, such as hyperlipidaemia, hypertension and glucose intolerance [4±6]. However, molecular mechanisms for the pathogenesis of obesity-accompanied metabolic disorders are not clear. So far, it has been clarified that adipose cells in visceral areas have different functions both in vivo and in vitro from the cells in subcutaneous areas, and these differences might contribute the pathological significance of visceral fat accumulation for accompanying insulin resistance and hyperinsulinaemia [7] . We have reported that patients with excessive visceral fat accumulation show delayed postprandial triglyceride (TG) metabolism compared to normal subjects, and the disturbed metabolism is, at least in part, caused by reduced lipoprotein lipase (LPL) mass and activity in their sera [8, 9] . In accordance with the clinical observations, model rats for Diabetologia (2002) Abstract Aims/hypothesis. Visceral adipocytes have different functions than those from the subcutaneous fat area. These differences could contribute to the pathological significance of excessive visceral fat accumulation for accompanying insulin resistance and hyperinsulinaemia. This study addresses this hypothesis and describes a unique method to clarify whether the functional differences between visceral and subcutaneous adipocytes depend on their anatomical location. Methods. 3T3-L1 cells or TNF-a overexpressing CHO cells were implanted into subcutaneous fat area or mesenteric area as visceral fat area in athymic mice of BALB/C strain. Then, serum insulin, glucose, TNF-a, and several markers of lipid metabolism were measured in the fasting condition. OGTT was also analysed.
excessive visceral fat accumulation revealed negative correlation between the serum concentration of insulin or TNF-a and the LPL mRNA expression in muscle and subcutaneous fat [10] . These in vivo results strongly suggest that visceral fat secretes cytokines such as TNF-a, and that this mechanism is the cause of insulin resistance in human beings as well as rodents.
Cultured adipose cells from visceral and subcutaneous fat have different activities of proliferation and lipid metabolism [11] . Furthermore, the different gene expression of visceral and subcutaneous fat in vivo has been clarified, and genes abundantly expressed in visceral fat have been identified using subtraction cloning [12, 13] . Although the different gene expressions and cell properties of visceral and subcutaneous fat have been observed, it is not clear why the adipose cells in a visceral area have a different function and gene expression from those in a subcutaneous area.
Recently, subcutaneously implanted adipose tissue has been reported to improve the glucose intolerance accompanied with lipoatrophic mice [14] . Subcutaneously implanted preadipocytes are able to secrete leptin, although not in vitro [15] . These observations suggest the adipose cells interact with the surrounding cells and tissues, and the functions of adipose cells might be modified by the stimuli from their surroundings. In this study, we clarified the molecular mechanism of different cell properties. The implantation of exogenous cells, in particular adipose cells, into nude mice modified the metabolic status associated with insulin resistance. Furthermore, these results using implantation methods indicate that TNF-a causes the metabolic disturbance associated with decreased insulin sensitivity in mice.
Materials and methods
Materials. DMEM, FBS, G418 and trypsin were obtained from Invitrogen Japan K. K. (Tokyo, Japan). PBS was from Nissui Pharmaceuticals (Tokyo, Japan).
Preadipocytes culture. 3T3-L1 cells, an established preadipocyte cell line, was obtained from the American Type Culture Collection (Manassas, Va, USA) and cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10 % FBS at 37 C in a 5 % CO 2 incubator.
Generation of human TNF-a overexpressing CHO cells. Human TNF-a cDNA was obtained by polymerase chain reaction from human placenta cDNA library using specific oligonucleotide primers. The cDNA fragment was subcloned into pcDNA3.1myc (Invitrogen, Japan K. K.) and sequenced. This plasmid is the expression vector for suffered protein tagged with myc epitope at carboxyl-terminus. The plasmids were transfected into CHO cells using lipofectAMINE reagent (Invitrogen Japan K. K.). The cells stably expressing hTNF-a were selected with G418 at the concentration of 0.5 mg/ml and subcloned. The hTNF-a overexpressing CHO cell clones were cultured in DMEM supplemented with 10 % FBS.
Cell transplantation. The 3T3-L1 preadipocytes were grown to near confluence, trypsinised and suspended in DMEM with 10 % FBS. After centrifugation, cell pellets were resuspended in PBS and injected with the amounts of 1 10 7 cells (500 ml) through 22 G needles into the mesenteric area close to the small intestine or subcutaneous fat area of nude mice (athymic BALB/C strain) under anaesthetic. Mice were housed in micro-isolator cages under specific pathogen-free conditions during the whole experiment. Each week after injection, body weight was measured. Blood samples were also collected in the fasting condition each week after implantation. Four weeks after 3T3-L1 cell implantation, an OGTT was performed. Then, the mice were killed by cervical dislocation before implanted mesenteric or subcutaneous adipose tissue area was collected. The hTNF-a overexpressing CHO cells were also injected with the amounts of 1 x 10 7 cells (500 ml) in mesenteric or subcutaneous area of the mice under the same conditions described above. Every week after injection, blood samples were collected. OGTT was performed at four weeks after transplantation.
Serum samples. Blood samples were obtained from retro-orbital venous plexus of the mice which had fasted over 16 h. Serum samples were immediately prepared by centrifugation at 1500 g for 15 min at 4 C. Serum glucose, TC, TG, and high density lipoprotein cholesterol (HDL-C) were measured with commercial kits (Wako chemicals, Osaka, Japan). Serum insulin was detected by ELISA kit (Morinaga, Yokohama, Japan). Human and mouse TNF-a were also determined by an enzyme-linked immunosorbent assay (BioSource International, Calif., USA).
Oral glucose tolerance test. Oral glucose tolerance test was performed on conscious mice after a 16 h fast. The test was done by orally administrated glucose (2 mg per g body weight) and measurement of blood glucose and insulin at 15 and 30 min after loading.
LPL mass and activity. Post-heparin plasma was obtained 10 min after intravenous injection of heparin at a dose of 50 mU per g of body weight. The lipoprotein lipase mass was determined by ELISA and its activity was determined using Triton X-100 emulsified triolein as already described [8] .
Histological analysis of implanted tissues. Four weeks after implantation with 3T3-L1 cell, the mice were killed by cervical dislocation before the implanted mesenteric or subcutaneous fat area was collected. For light microscopic analysis, the tissues from implanted mesenteric or subcutaneous fat area were paraffin-embedded after 24 h of fixation in neutral-buffered formaldehyde. Four-to six-mm tissue sections were stained with hematoxylin and eosin for histological analysis.
Reverse transcription-polymerase chain reaction. Four weeks after implantation with 3T3-L1 cell, the mice were killed by cervical dislocation before mesenteric or subcutaneous fat area or femoral muscle was collected. Total RNA was isolated with an RNA extraction kit (Qiagen K. K., Tokyo, Japan). To evaluate the contents of TNF-a expression, 2.0 mg of total RNA was amplified by OneStep RT-PCR kit (Qiagen K. K.) using the specific primers. The PCR products were run on 2.0 % agarose and stained with ethidium bromide. The relative signal intensities of the PCR products were determined with luminescent image analyser LAS-1000 (Fuji Photo Film, Tokyo, Japan). mRNA amounts were normalised to levels of beta-actin mRNA, which served as endogenous standard.
The primers. Primers synthesised for TNF-a were 5' GGCAGGTCTACTTTGGAGTCATTGC 3' and 5' ACATT-CGAGGCTCCAGTGAATTC GG 3' according to known cDNA sequence. Primers for beta-actin were 5' TGGAATCC-TGTGGCATCCATGAAAC 3' and 5' TAAAACGCAGCT-CAGTAACAGTCCG 3'.
Statistical analysis. Statistical analysis was performed with t test. All the results reported herein were confirmed by repeating the experiments with different occasions.
Results
The effects of implantation of 3T3-L1 preadipocytes into the mesenteric or subcutaneous area of nude mice. We implanted the 3T3-L1 preadipocytes into mesenteric and subcutaneous areas in which cell cluster is not usually observed in nude mice. Thickened pad formation was found in mesenteric area in which preadipocytes were injected. Histological findings at four weeks after implantation clearly showed cell cluster formation in mesenteric area ( Fig. 1A and C) . The 3T3-L1 preadipocytes implanted into subcutaneous fat area formed cell cluster ( Fig. 1B and D) . In implanted areas, cell density was much higher than in control mice. Vascular structures were observed in implanted areas to be the same as non-implanted areas. Round cell infiltration surrounded capillaries and degenerated tissues were not found at any areas implanted with 3T3-L1 cells.
The serum concentrations of TNF-a increased gradually after implantation with 3T3-L1 cells into mesenteric area, and these reached 141.6 30.9 pg/ml at four weeks. However, the mice which had been injected in subcutaneous area did not show any difference from those of Sham-operated mice ( Fig. 2A) . Body weight during experimental periods did not differ among the mice implanted with 3T3-L1 cells into mesenteric and subcutaneous area, and control (Fig. 2B) .
OGTT was analysed at four weeks after implantation (Fig. 3) . The glucose concentrations did not show any difference between the mice implanted with 3T3-L1 cells into mesenteric area and control (Fig. 3A) . However, serum insulin concentrations during the course of glucose loading were apparently higher in the mice implanted into mesenteric area than in control mice (Fig. 3C ). The area under the curve of insulin concentrations in the mice implanted into mesenteric area was 3.2-fold higher than that in control mice (p < 0.005 vs control) (Fig. 3E) . Furthermore, the glucose and insulin ratios at 15 min after loading were negatively correlated with the serum concentrations of TNF-a (p < 0.05, r = 0.45) (Fig. 3F) . These results indicate that the insulin sensitivity in mice could be determined by the serum TNFa concentration caused by the secretion from the implanted cells. On the other hand, the serum glucose concentrations after loading were lower in the mice implanted with 3T3-L1 cells into the subcutaneous area than in control mice (p < 0.05) (Fig. 3B) . Moreover, serum insulin concentrations were also apparently lower in the mice implanted into subcutaneous area than control mice (Fig. 3D) . The area under the curve of insulin concentrations in the mice implanted into subcutaneous area was 0.67-fold lower than that in control mice (p < 0.05 vs control) (Fig. 3E) . These results suggest that 3T3-L1 cells implanted into subcutaneous area improve glucose metabolism. We performed RT-PCR analysis for the gene expression of TNF-a in the implanted mesenteric or subcutaneous fat area using specific oligonucleotide primers. As shown in Figure 4A , the contents of TNF-a expression were increased 4.5-fold in the mesenteric fat implanted with 3T3-L1 cells than those in control mice (p < 0.01 vs control). However, the TNF-a expression in the subcutaneous fat were 0.3-fold lower in the mice implanted into mesenteric area than in control mice (p < 0.01 vs control) (Fig. 4B) . In contrast, the contents of TNF-a expression of mesenteric or subcutaneous area were almost the same in the mice implanted with 3T3-L1 cells into subcutaneous area and control ( Fig. 4A and 4B) . Moreover, TNF-a expression in femoral muscles did not show any difference among the mice implanted into mesenteric and subcutaneous area, and control (Fig. 4C) . These results suggest that the localisation of adipose tissues is important for the cellular function, even if the implanted cells are preadipocyte, not mature adipocytes.
The lipid profile in the serum showed a significant increase in TG concentrations of mice implanted into the mesenteric area, compared to those of mice implanted into subcutaneous area and control mice, although the concentrations of TC and HDL-C did not (Table 1) .
We next carried out the correlation analysis of insulin or TNF-a and LPL mass and activity (Fig. 5) . Post-heparin LPL mass was negatively correlated with serum concentrations of insulin and TNF-a in the mice implanted with 3T3-L1 cells into mesenteric area. Post-heparin LPL activity was also negatively correlated with insulin and TNF-a. Major sources of LPL expression were muscle and adipose tissues [16] . Thus, the LPL expression in muscle and adipose tissues seems to be dependent on the serum insulin and TNF-a concentrations regulated by the implanted 3T3-L1 preadipocytes in mice. These results suggest that implanted preadipocytes function affected by the surrounding conditions, and the secreted TNF-a is the key regulator of the metabolic disorders such as hypertriglyceridaemia accompanied with insulin resistance.
The effects of implantation of hTNF-a secreting CHO cells in nude mice. To investigate the influence of location of adipose tissues for the determination of insulin sensitivity, we established the hTNF-a overexpressing CHO cell clones because cytokine has been reported to cause insulin resistance in mice using knockout technology. The CHO cells stably transfected with human TNF-a cDNA showed detectable concentration of the cytokine at 40 ng/ml in the cultured medium, whereas it was not detectable in the medium with mock-transfected cells. Western blot analysis of conditioned medium from hTNF-a overexpressing CHO cells using anti-myc antibody as primary antibody revealed that the molecular weight of secreted TNF-a was 23 kDa, as expected (data not shown).
The hTNF-a overexpressing CHO cells were implanted into the back of nude mice subcutaneously (Fig. 6A) . The serum concentrations of hTNF-a increased gradually after implantation into subcutaneous fat area, and these reached to 2345 2035 pg/ ml at four weeks. However, the control mice injected with CHO cells transfected with mock vector, did not show any detectable values during the course of observation (Fig. 6B) . Body weight during experimental periods did not differ between the mice implanted with hTNF-a overexpressing CHO cells and control (Fig. 6C) .
The metabolic markers indicating for insulin sensitivity were analysed at four weeks after implantation (Fig. 7) . OGTT did not show any difference of the serum glucose concentrations between the mice implanted with hTNF-a overexpressing cells into subcutaneous area and control (Fig. 7A) . However, serum insulin concentrations during the course of glucose loading were apparently higher in the mice implanted with hTNF-a overexpressing cells than in control mice (Fig. 7B) . The area under the curve of insulin concentrations in the mice implanted with TNF-a overexpressing cells was twofold higher than that in control mice (p < 0.001 vs control) (Fig. 7C) . Furthermore, the glucose and insulin ratios at 15 min after loading were negatively correlated with the serum hTNF-a concentrations (Fig. 7D) . These results indicate that the insulin sensitivity in mice is possibly determined by the serum TNF-a concentration caused by the secretion from the implanted cells. Moreover, the glucose and insulin concentrations did not show any difference between the mice implanted with hTNF-a overexpressing cells into subcutaneous or 
Discussion
In this study, we showed that the implantation of 3T3-L1 preadipocytes revealed that the transplanted areas have an important role in the systemic metabolism associated with insulin sensitivity, suggesting that the cellular function is dependent on the surrounding conditions. Furthermore, TNF-a overexpression in the subcutaneous area of mice induces hyperinsulinaemia probably associated with reduced insulin sensitivity. The ratio of insulin and glucose concentrations in their sera were negatively correlated with serum TNF-a concentrations.
In culture system, the proliferation rate of preadipocyte derived from subcutaneous fat was faster than that from visceral fat, whereas lipid synthesis from glucose or free fatty acids in visceral adipocytes was more enhanced than that in subcutaneous adipocytes [11] . These results suggest that the visceral and subcutaneous adipocytes might be genetically different. On the other hand, 3T3-L1 preadipocytes in the culture system express leptin at extremely low levels and the expression in culture is not responsive to many physiological agents that have been seen to affect leptin expression in vivo [17] . However, these cells acquire the capacity to express leptin when implanted into subcutaneous area [17] . The results in this study suggest that adipocytes are able to change or modify the cellular function depending on the conditions such as in vivo and in vitro, or subcutaneous and mesenteric areas. These findings together with our results might suggest that adipocytes require the some factors or conditions, present in an in vivo tissue context when the preadipocytes give full play to their own function.
Furthermore, we showed in this study that TNF-a is a key regulator for insulin sensitivity, which accompanies metabolic disorders. TNF-a is known to be important for the regulation of insulin sensitivity in mice using knockout technology [18, 19] . In addition, our results firstly clarified that the location of the source of TNF-a secretion is the pathologically important for the development of insulin resistance and its related disorders. In particular, the expression of LPL is an extremely sensitive marker for the insulin resistance-induced complications. In this context, we have shown that the negative correlation between the serum concentrations of TNF-a or insulin and the LPL mRNA expression in muscle and subcutaneous fat using the model rats for excessive visceral fat accumulation [10] . These results suggest that the amount of TNF-a secretion in adipocytes is one of the most distinct determinants for the difference of functions observed in subcutaneous and visceral fat tissues. In summary, this method of adipose cell implantation affects the systemic metabolism associated with insulin sensitivity, probably suggesting that the cellular function is dependent on the surrounding conditions, in addition to their genetic backgrounds. These characteristics of adipocytes might make it possible to establish a new implantation method to improve the metabolic disorders associated with insulin resistance.
